Union Quimico Farmaceutica Fails EDQM Inspection
Enforcement Report - Week of October 3, 2018
According to the press release on December 30, 2017, Zydus Pharmaceuticals (USA) Inc., a wholly owned subsidiary of Cadila Healthcare Ltd and part of Zydus group, has received the final approval from the USFDA to market Valacyclovir USP in strengths of 500 mg and 1 gm.
Zydus Pharm`s Generic Valacyclovir Hydrochloride Receives Approval In US
GSK has temporarily halted production of Ventolin HFA inhalers at its plant in Zebulon, North Carolina while it investigates customer complaints.
Anti-Herpes Drug May Help Treat HIV: Study
Market Place
Share
Share
Share Share
